The clinical trial collaboration (nextHerizon) with MSD was initiated 45 days ago and now terminated by IMU
SP was not appreciated after they signed the deal anyway
No cost for this collaboration so far beside the admin costs
And nothing to do with the effectiveness of Hervaxx ever so as the trail was not even started yet. MSD would not walk away unless there's supplying problem of its own products or Hervaxx is sold (my take)
The NeoHerizon with Merck KGaA and Pfizer is still going
Ann: Termination of Supply Agreement, page-114
-
- There are more pages in this discussion • 335 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.004(6.48%) |
Mkt cap ! $422.5M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.154M | 20.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 2044881 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 1313685 | 16 |
View Market Depth
| Last trade - 15.18pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |